Evidence map›Paper›PMID 41417200›Full record

ReviewPharmacological reports : PR2026

Common features in the gut microbiota of underweight and overweight individuals and patients with Parkinson's disease - a mini-review.

Emilia Kaczorowska, Aleksandra Tarasiuk-Zawadzka, Karolina Ratajczyk, Karolina Wyka, Agata Gajos, Jakub Fichna

Abstract readReview
In one paragraph

Review in Pharmacological reports : PR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emilia KaczorowskaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 5, Łódź, 92-215, Poland.ORCID http://orcid.org/0009-0001-8675-350X
Aleksandra Tarasiuk-ZawadzkaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 5, Łódź, 92-215, Poland.ORCID http://orcid.org/0000-0002-5306-3158
Karolina RatajczykDepartment of Neurology, Karol Jonscher's Municipal Medical Center, Milionowa 14, Łódź, 93-113, Poland.ORCID http://orcid.org/0009-0002-3817-3532
Karolina WykaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 5, Łódź, 92-215, Poland.ORCID http://orcid.org/0009-0007-0741-3878
Agata GajosDepartment of Extrapyramidal Diseases, Medical University of Lodz, Central University Hospital, Pomorska 251, Lodz, Łódź, 92-216, Poland.ORCID http://orcid.org/0000-0002-3753-6197
Jakub FichnaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 5, Łódź, 92-215, Poland. jakub.fichna@umed.lodz.pl.ORCID http://orcid.org/0000-0002-8443-4417

Funding

Uniwersytet Medyczny w Lodzi 503/1-156-04/503-11-001Uniwersytet Medyczny w Lodzi 503/6-127-01/503-61-001
6 · The paper itself

Abstract

This study explores the complex relationship between gut microbiota composition, body weight, and Parkinson’s disease (PD). Recognizing that microbiota profiles vary across Body Mass Index (BMI) categories: underweight, normal weight, and overweight, here we investigate how these differences may correlate with PD pathogenesis and the severity of the disease. The findings highlight common dysbiotic features, such as increased pro-inflammatory bacteria, observed in both PD and obesity, suggesting the involvement of shared inflammatory pathways in disease development. Conversely, all three groups: individuals with underweight, obesity, and PD exhibit reduced abundance of beneficial bacteria, which potentially impairs immune and metabolic functions, such as carbohydrate turnover and short-chain fatty acids (SCFAs) delivery. Following this analysis, we focus on and briefly discuss dietary patterns, which emerge as key modulators of gut microbiota. Plant-based and Mediterranean diets promote beneficial microbes and SCFAs production, while diets high in saturated fats and processed foods contribute to detrimental microbial shifts. Understanding these interactions underscores the importance of personalized approaches (including nutritional) targeting gut microbiota modulation as potential therapeutic avenues in PD. This integrative perspective advocates for further multidisciplinary research to elucidate causal mechanisms and develop microbiota-focused interventions aimed at delaying neurodegeneration and improving PD patient outcomes.

Indexed as

Gastrointestinal MicrobiomeOverweightParkinson DiseaseThinnessAnimalsBody Mass IndexHumansObesityBody weightMediterranean dietMicrobiotaParkinson’s diseasePlant-based diet

Identifiers

PMID41417200
PMCPMC12795860

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.